Cabaletta Bio
Michael Cooper has worked for four different companies in the past few years. In 2020, they began their current role as Director of GCP Compliance for Cabaletta Bio. Prior to this, they were a Board Member for Men of Courage from 2019 to 2020, a Member Board of Directors for The Monkey and the Elephant Coffee Shop from 2017 to 2019, and an Associate Director of Compliance for Adaptimmune US from 2014 to 2017.
Michael Cooper attended Middle Tennessee State University (MTSU) from 2000 to 2004.
This person is not in the org chart
Cabaletta Bio
2 followers
Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases.